Corrigenda and Addenda
doi:10.2196/65322
In “Effectiveness of the Pasifika Women’s Diabetes Wellness Program (PWDWP): Protocol for a Pilot Intervention and Feasibility Randomized Controlled Trial” (JMIR Res Protoc 2024;13:e55435) the authors made three additions.
A section of text has been added to the “Acknowledgements” that reads as follows:
The MMAS-8 Scale (U.S. Copyright Registration No. TX0008632533), content, name, and trademarks are protected by US copyright and trademark laws. Permission for use of the scale and its coding is required. A license agreement is available from MMAR, LLC., www.moriskyscale.com
Additionally, two citations will be added after Reference 28 in the second paragraph of the “Objectives” section which appeared as:
The secondary objective is to determine whether, compared with control participants, the intervention group achieves changes to bring body composition measurements closer to the recommended healthy range for specific cultural groups (eg, BMI ≤30 kg/m2 and waist circumference <80 cm based on World Health Organization criteria) and improved diabetes self-care scores on diet, physical activity, routine health checks, and medication adherence assessed using the validated Summary of Diabetes Self-Care Activities scale [23,25-31].
This will now be changed to read as:
The secondary objective is to determine whether, compared with control participants, the intervention group achieves changes to bring body composition measurements closer to the recommended healthy range for specific cultural groups (eg, BMI ≤30 kg/m2 and waist circumference <80 cm based on World Health Organization criteria) and improved diabetes self-care scores on diet, physical activity, routine health checks, and medication adherence assessed using the validated Summary of Diabetes Self-Care Activities scale [23,25-33].
The references added are as follows, with all subsequent references reordered accordingly:
29. Berlowitz DR, Foy CG, Kazis LE, Bolin L, Conroy LB, Fitzpatrick P, et al. for the SPRINT Study Research Group. Impact of Intensive Blood Pressure Therapy on Patient-Reported Outcomes: Outcomes Results from the SPRINT Study. N Engl J Med 2017; 377:733-44.
30. Bress AP, Bellows BK, King J, Hess R, Beddhu S, Zhang Z, et al, for the SPRINT Research Group and the SPRINT Economics and Health Related Quality of Life Subcommittee. Cost- Effectiveness of Intensive versus Standard Blood Pressure Control. N Engl J Med 2017; 377:745-55.
The correction will appear in the online version of the paper on the JMIR Publications website on August 26, 2024, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.
This is a non–peer-reviewed article. submitted 12.08.24; accepted 13.08.24; published 26.08.24.
Copyright©Heena Akbar, Madison Contor, Winnie Niumata, Debra Anderson, Danielle Gallegos. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.08.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.